Investment Rating - The report maintains a "Recommended" rating for the company, indicating a positive outlook for its stock performance in the near future [6]. Core Insights - The company has demonstrated strong revenue growth driven by innovation, with a projected revenue increase from 8.43 billion CNY in 2023 to 15.90 billion CNY by 2026, reflecting a compound annual growth rate (CAGR) of approximately 24.22% [2][8]. - The net profit attributable to shareholders is expected to grow from 0.88 billion CNY in 2023 to 1.35 billion CNY in 2026, with a notable profit growth rate of 52.92% in 2023, followed by more moderate growth in subsequent years [2][8]. - The company is actively expanding its production capacity, increasing its investment in the "Sports Nutrition Food Production Base" from 126 million CNY to 309 million CNY, which will enhance its market position and supply capabilities [6][8]. Financial Forecast Summary - Revenue Forecast: - 2023: 8.43 billion CNY - 2024: 10.41 billion CNY (growth rate: 23.46%) - 2025: 12.80 billion CNY (growth rate: 22.96%) - 2026: 15.90 billion CNY (growth rate: 24.22%) [2][8] - Net Profit Forecast: - 2023: 0.88 billion CNY - 2024: 0.89 billion CNY (growth rate: 1.58%) - 2025: 1.11 billion CNY (growth rate: 23.61%) - 2026: 1.35 billion CNY (growth rate: 22.11%) [2][8] - Earnings Per Share (EPS): - 2023: 0.71 CNY - 2024: 0.72 CNY - 2025: 0.89 CNY - 2026: 1.09 CNY [2][8] Market Position and Product Innovation - The company is focusing on continuous product innovation, with the introduction of new formulations and flavors, which is expected to significantly boost sales in the sports nutrition sector [6][8]. - The sports nutrition market in China is still developing, with low penetration rates, indicating substantial growth potential for the company as consumer awareness and demand for nutritional supplements increase [6][8].
康比特：快报点评：创新驱动营收增长，扩产展望业绩提升-20250307